drugset

drugset / Trial / NCT06937528

Use of Extracellular Vesicles (EV) for Knee Osteoarthrosis

NCT06937528 ↗

Phase 1 Recruiting 50 enrolled University of Jordan Abdalla Awidi Abbadi, MD · collab

NaSingle-groupOpen-labelTreatment

Summary

Extracellular vesicles (EV) will be injected in patients diagnosed with Knee osteoarthrosis

Timeline

Start: 2024-01-01
Primary completion: 2026-01-30
Completion: 2027-01-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Exosome	Other / unclassified	—	Other

Indications